We, at Kimialys, partner with leading biotech and pharmaceutical companies, offering advanced analysis services for their biophysical studies. With a blend of deep expertise in Surface Plasmon Resonance (SPR) and our K-One® technological edge, our capabilities are limitless as we can immobilize any ligand, analyze any complex sample, allowing for unprecedented SPR analysis (affinity, avidity), all while maintaining a high level of reliability. 

Our proprietary and patented chemical treatment also applies to nanoparticles, enabling the development of ultra-sensitive immuno-PCR (iPCR) assays, as well as advancing the drug tolerance of standard Anti-Drug Antibodies (ADA) assays. 

We are an ISO 9001 certified company based in France, working with laboratories across Europe, North America, and Asia.